Beta Drugs (NSE:BETA) Total Liabilities : ₹1,136 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Total Liabilities?

Beta Drugs's Total Liabilities for the quarter that ended in Sep. 2024 was ₹1,136 Mil.

Beta Drugs's quarterly Total Liabilities increased from Sep. 2023 (₹952.89 Mil) to Mar. 2024 (₹969.82 Mil) and increased from Mar. 2024 (₹969.82 Mil) to Sep. 2024 (₹1,136.46 Mil).

Beta Drugs's annual Total Liabilities increased from Mar. 2022 (₹655.10 Mil) to Mar. 2023 (₹755.37 Mil) and increased from Mar. 2023 (₹755.37 Mil) to Mar. 2024 (₹969.82 Mil).

Beta Drugs Total Liabilities Historical Data

The historical data trend for Beta Drugs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Total Liabilities Chart

Beta Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

500.64

488.93

655.10

755.37

969.82

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Total Liabilities	Get a 7-Day Free Trial															672.00	755.37	952.89	969.82	1,136.46

Beta Drugs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beta Drugs's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	846.689	+	(60.407	+	40.931
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	21.79)
	=	970

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	2540.986	-	1571.169
	=	970

Beta Drugs's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	972.488	+	(101.731	+	62.238
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,136

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	2945.062	-	1808.605
	=	1,136

Beta Drugs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines